Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 104

    1.

    Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials.

    Mount DL, Feeney P, Fabricatore AN, Coday M, Bahnson J, Byington R, Phelan S, Wilmoth S, Knowler WC, Hramiak I, Osei K, Sweeney ME, Espeland MA; Look AHEAD and ACCORD Research Groups.

    Clin Trials. 2009 Oct;6(5):416-29. Epub 2009 Sep 8.PMID: 19737845 [PubMed - in process]Related articles

    2.

    Metabolic syndrome in Black people of the African diaspora: the paradox of current classification, definition and criteria.

    Gaillard T, Schuster D, Osei K.

    Ethn Dis. 2009 Spring;19(2 Suppl 2):S2-1-7. Review.PMID: 19537240 [PubMed - indexed for MEDLINE]Related articles

    3.

    Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus.

    Norris LE, Collene AL, Asp ML, Hsu JC, Liu LF, Richardson JR, Li D, Bell D, Osei K, Jackson RD, Belury MA.

    Am J Clin Nutr. 2009 Sep;90(3):468-76. Epub 2009 Jun 17.PMID: 19535429 [PubMed - indexed for MEDLINE]Related articles

    4.

    Comparison of the portal vein and kidney subcapsule as sites for primate islet autotransplantation.

    Rajab A, Buss J, Diakoff E, Hadley GA, Osei K, Ferguson RM.

    Cell Transplant. 2008;17(9):1015-23.PMID: 19177838 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience.

    Barnett CF, Bonura EJ, Nathan SD, Ahmad S, Shlobin OA, Osei K, Zaiman AL, Hassoun PM, Moller DR, Barnett SD, Girgis RE.

    Chest. 2009 Jun;135(6):1455-61. Epub 2008 Dec 31.PMID: 19118270 [PubMed - indexed for MEDLINE]Related articles

    6.

    The cardiometabolic syndrome in persons of the African diaspora: challenges and opportunities.

    Schuster DP, Gaillard T, Osei K.

    J Cardiometab Syndr. 2007 Fall;2(4):260-6. Review.PMID: 18059209 [PubMed - indexed for MEDLINE]Related articles

    7.

    Importance of aerobic fitness in cardiovascular risks in sedentary overweight and obese African-American women.

    Gaillard TR, Sherman WM, Devor ST, Kirby TE, Osei K.

    Nurs Res. 2007 Nov-Dec;56(6):407-15.PMID: 18004187 [PubMed - indexed for MEDLINE]Related articles

    8.

    Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

    Bonds DE, Kurashige EM, Bergenstal R, Brillon D, Domanski M, Felicetta JV, Fonseca VA, Hall K, Hramiak I, Miller ME, Osei K, Simons-Morton DG; ACCORD Study Group.

    Am J Cardiol. 2007 Jun 18;99(12A):80i-89i. Epub 2007 Apr 17.PMID: 17599428 [PubMed - indexed for MEDLINE]Related articles

    9.

    Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals with insulin resistance.

    Stakos DA, Schuster DP, Sparks EA, Meis SB, Wooley CF, Osei K, Boudoulas H.

    Eur J Endocrinol. 2007 Jul;157(1):63-8.PMID: 17609403 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus.

    Jain R, Osei K, Kupfer S, Perez AT, Zhang J.

    Pharmacotherapy. 2006 Oct;26(10):1388-95.PMID: 16999648 [PubMed - indexed for MEDLINE]Related articles

    13.
    14.

    Cardiovascular effects of type 1 diabetes mellitus in children.

    Stakos DA, Schuster DP, Sparks EA, Wooley CF, Osei K, Boudoulas H.

    Angiology. 2005 May-Jun;56(3):311-7.PMID: 15889199 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with T2DM.

    Feinglos M, Dailey G, Cefalu W, Osei K, Tayek J, Canovatchel W, Chaiken R, Kourides I.

    Diabetes Res Clin Pract. 2005 May;68(2):167-75.PMID: 15860246 [PubMed - indexed for MEDLINE]Related articles

    16.

    Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomised study.

    Stakos DA, Schuster DP, Sparks EA, Wooley CF, Osei K, Boudoulas H.

    Heart. 2005 May;91(5):589-94.PMID: 15831640 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

    Osei K, Gaillard T, Schuster D.

    Obes Res. 2005 Jan;13(1):179-85.PMID: 15761178 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes.

    Osei K, Gaillard T, Kaplow J, Bullock M, Schuster D.

    Metabolism. 2004 Dec;53(12):1552-7.PMID: 15562399 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impact of metformin on glucose metabolism in nondiabetic, obese African Americans: a placebo-controlled, 24-month randomized study.

    Schuster D, Gaillard T, Rhinesmith S, Habash D, Osei K.

    Diabetes Care. 2004 Nov;27(11):2768-9. No abstract available. PMID: 15505024 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Community-based cluster surveys on treatment preferences for diarrhoea, severe diarrhoea, and dysentery in children aged less than five years in two districts of Ghana.

    Biritwum RB, Asante A, Amoo PK, Gyekye AA, Amissah CR, Osei KG, Appiah-Poku YA, Welbeck JE.

    J Health Popul Nutr. 2004 Jun;22(2):182-90.PMID: 15473521 [PubMed - indexed for MEDLINE]Related articles

    22.

    Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm.

    Saad MF, Greco S, Osei K, Lewin AJ, Edwards C, Nunez M, Reinhardt RR; Ragaglitazar Dose-Ranging Study Group.

    Diabetes Care. 2004 Jun;27(6):1324-9.PMID: 15161783 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Metabolism. 2004 Apr;53(4):414-22.PMID: 15045685 [PubMed - indexed for MEDLINE]Related articles

    24.

    Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    J Clin Endocrinol Metab. 2003 Oct;88(10):4596-601.PMID: 14557428 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study.

    Schuster D, Gaillard T, Rhinesmith S, Habash D, Osei K.

    Metabolism. 2003 Sep;52(9):1211-7.PMID: 14506629 [PubMed - indexed for MEDLINE]Related articles

    26.

    Global epidemic of type 2 diabetes: implications for developing countries.

    Osei K.

    Ethn Dis. 2003 Summer;13(2 Suppl 2):S102-6.PMID: 13677423 [PubMed - indexed for MEDLINE]Related articles

    27.

    Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians.

    Amoah AG, Schuster DP, Gaillard T, Osei K.

    Diabetologia. 2003 Jul;46(7):949-55. Epub 2003 Jun 18.PMID: 12819902 [PubMed - indexed for MEDLINE]Related articles

    29.

    Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.

    Stakos DA, Schuster DP, Sparks EA, Wooley CF, Osei K, Boudoulas H.

    J Cardiol. 2003 Apr;41(4):183-90.PMID: 12728539 [PubMed - indexed for MEDLINE]Related articles

    30.

    Diabetes in Africa. Pathogenesis of type 1 and type 2 diabetes mellitus in sub-Saharan Africa: implications for transitional populations.

    Osei K, Schuster DP, Amoah AG, Owusu SK.

    J Cardiovasc Risk. 2003 Apr;10(2):85-96. Review.PMID: 12668905 [PubMed - indexed for MEDLINE]Related articles

    31.

    Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.

    Amoah AG, Schuster DP, Gaillard T, Osei K.

    Ethn Dis. 2002 Fall;12(4):S3-10-7.PMID: 12477148 [PubMed - indexed for MEDLINE]Related articles

    32.

    Patient survival after renal transplantation: IV. Impact of post-transplant diabetes.

    Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM.

    Kidney Int. 2002 Oct;62(4):1440-6.PMID: 12234317 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.

    Amoah AG, Owusu SK, Schuster DP, Osei K.

    S Afr Med J. 2002 May;92(5):377-84.PMID: 12108171 [PubMed - indexed for MEDLINE]Related articles

    35.

    Cardiovascular effects of aging. Interrelationships of aortic, left ventricular, and left atrial function.

    Kallaras K, Sparks EA, Schuster DP, Osei K, Wooley CF, Boudoulas H.

    Herz. 2001 Mar;26(2):129-39.PMID: 11349615 [PubMed - indexed for MEDLINE]Related articles

    36.

    Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.

    Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM.

    Kidney Int. 2001 Feb;59(2):732-7.PMID: 11168956 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Significance of parental history of type 2 diabetes on insulin sensitivity and glucose effectiveness in obese nondiabetic offspring of African-American patients.

    Osei K, Gaillard T, Schuster DP.

    Diabetes Care. 1999 Sep;22(9):1594-6. No abstract available. PMID: 10480538 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Cardiovascular risk factors in African-Americans with varying degrees of glucose intolerance.

    Osei K, Gaillard T, Schuster DP.

    Diabetes Care. 1999 Sep;22(9):1588-90. No abstract available. PMID: 10480533 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Insulin resistance and systemic hypertension.

    Osei K.

    Am J Cardiol. 1999 Jul 8;84(1A):33J-36J. Review.PMID: 10418857 [PubMed - indexed for MEDLINE]Related articles

    40.

    Metabolic consequences of the West African diaspora: lessons from the thrifty gene.

    Osei K.

    J Lab Clin Med. 1999 Feb;133(2):98-111. Review. No abstract available. PMID: 9989761 [PubMed - indexed for MEDLINE]Related articles

    41.

    Post-transplantation hypoglycaemia in type 1 diabetic pancreas allograft recipients.

    Osei K.

    Acta Diabetol. 1998 Dec;35(4):176-82. Review.PMID: 9934815 [PubMed - indexed for MEDLINE]Related articles

    42.

    Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus.

    Gaillard TR, Schuster DP, Osei K.

    Ethn Dis. 1998 Autumn;8(3):319-30.PMID: 9926902 [PubMed - indexed for MEDLINE]Related articles

    43.

    Facilities and resources for diabetes care at regional health facilities in southern Ghana.

    Amoah AG, Owusu SK, Saunders JT, Fang WL, Asare HA, Pastors JG, Sanborn C, Barrett EJ, Woode MK, Osei K.

    Diabetes Res Clin Pract. 1998 Nov;42(2):123-30.PMID: 9886749 [PubMed - indexed for MEDLINE]Related articles

    44.

    Differential impact of obesity on glucose metabolism in black and white American adolescents.

    Schuster DP, Kien CL, Osei K.

    Am J Med Sci. 1998 Dec;316(6):361-7.PMID: 9856689 [PubMed - indexed for MEDLINE]Related articles

    46.

    Do sociodemographics and economic status predict risks for type II diabetes in African Americans?

    Gaillard TR, Schuster DP, Bossetti BM, Green PA, Osei K.

    Diabetes Educ. 1997 May-Jun;23(3):294-300.PMID: 9257620 [PubMed - indexed for MEDLINE]Related articles

    47.

    The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.

    Gaillard TR, Schuster DP, Bossetti BM, Green PA, Osei K.

    Diabetes Care. 1997 May;20(5):745-52.PMID: 9135936 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...